18.815 -0.165 (-0.87%) | 06-17 10:06 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 22.72 | 1-year : | 26.54 |
Resists | First : | 19.45 | Second : | 22.72 |
Pivot price | 18.72 ![]() |
|||
Supports | First : | 17.57 | Second : | 16.4 |
MAs | MA(5) : | 18.88 ![]() |
MA(20) : | 18.34 ![]() |
MA(100) : | 18.18 ![]() |
MA(250) : | 18.42 ![]() |
|
MACD | MACD : | 0.4 ![]() |
Signal : | 0.4 ![]() |
%K %D | K(14,3) : | 71.4 ![]() |
D(3) : | 75.6 ![]() |
RSI | RSI(14): 58.2 ![]() |
|||
52-week | High : | 23 | Low : | 14.22 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NVST ] has closed below upper band by 34.1%. Bollinger Bands are 60.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 19.07 - 19.17 | 19.17 - 19.26 |
Low: | 18.17 - 18.27 | 18.27 - 18.37 |
Close: | 18.82 - 18.98 | 18.98 - 19.14 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Mon, 16 Jun 2025
(NVST) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Fri, 13 Jun 2025
Envista Holdings reports annual meeting results By Investing.com - Investing.com Nigeria
Thu, 12 Jun 2025
Envista Holdings Holds 2025 Annual Stockholders Meeting - TipRanks
Tue, 10 Jun 2025
All You Need to Know About Envista (NVST) Rating Upgrade to Buy - Yahoo Finance
Wed, 28 May 2025
Baird Upgrades Envista Holdings (NVST) Stock to Outperform, Raises PT - MSN
Thu, 22 May 2025
Envista Leadership to Share Strategic Vision at Exclusive Stifel Healthcare Conference - Stock Titan
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Equipment & Services
|
|
Shares Out | 169 (M) |
Shares Float | 169 (M) |
Held by Insiders | 0.5 (%) |
Held by Institutions | 117.3 (%) |
Shares Short | 9,290 (K) |
Shares Short P.Month | 11,320 (K) |
EPS | -6.54 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 17.7 |
Profit Margin | -45 % |
Operating Margin | 7.9 % |
Return on Assets (ttm) | 1.5 % |
Return on Equity (ttm) | -31.4 % |
Qtrly Rev. Growth | -1.2 % |
Gross Profit (p.s.) | 8.08 |
Sales Per Share | 14.75 |
EBITDA (p.s.) | 1.59 |
Qtrly Earnings Growth | -27.3 % |
Operating Cash Flow | 297 (M) |
Levered Free Cash Flow | 334 (M) |
PE Ratio | -2.9 |
PEG Ratio | 0 |
Price to Book value | 1.06 |
Price to Sales | 1.28 |
Price to Cash Flow | 10.81 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |